Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-21
2010-06-29
Sullivan, Daniel M (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S566000, C548S567000, C564S175000
Reexamination Certificate
active
07745642
ABSTRACT:
The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.
REFERENCES:
patent: 2746959 (1956-05-01), Bruce et al.
patent: 3145209 (1964-08-01), Krapcho
patent: 5194644 (1993-03-01), Brunner et al.
patent: 2005/0267152 (2005-12-01), Bloomfield et al.
patent: 2861073 (2003-10-01), None
patent: 1410011 (1975-10-01), None
patent: WO 99/44596 (1999-09-01), None
patent: WO 01/81308 (2001-11-01), None
patent: WO 03/010132 (2003-02-01), None
patent: WO 03/055478 (2003-07-01), None
patent: WO 2004/072034 (2004-08-01), None
patent: WO 2004/098589 (2004-11-01), None
patent: WO 2005/023260 (2005-03-01), None
patent: WO 2005/037782 (2005-04-01), None
patent: WO 2005/037785 (2005-04-01), None
patent: WO 2005/095343 (2005-10-01), None
patent: WO 2005/103042 (2005-11-01), None
patent: WO 2005/110983 (2005-11-01), None
patent: WO 2006/067414 (2006-06-01), None
patent: WO 2006/067417 (2006-06-01), None
patent: WO 2006/067423 (2006-06-01), None
patent: WO 2007/147831 (2007-12-01), None
Adams et al. J. Org. Chem. 1998, 63, p. 9932-9934.
Javitt, Biol. Psychiatry 2008, 63, p. 6-8.
A Viso et al, Highly diatereoselective [3+2]cycloadditions between nonracemic p-Tolylsulfinimines and iminoesters: An efficient entry to enantiopure imidazolidines and vicinal diaminoalcohol; Chem. Eur. J, 2003, vol. 9, p. 2867-2876.
P N Becker et al, A New Method for 1,2-Diamination of Alkenes Using Cyclopentadienylnitrosylcobalt Dimer/NO/LiAIH4; J. Am Chem. Soc., 1980, vol. 102, p5676-5677.
Kindai Chemical lndstry Co, Japan; Chemical abstract: “Sizing of Paper”; Chemical abstracts service (online), 1982.
Sandra M Lechner, Elsevier Limited, Glutamate-based therapeutic approaches: inhibitors of glycine transport; Current Opinion in Pharmacology, Dec. 22, 2005, vol. 6, p75-81.
Basolo F et al, Steric effects and the stability of complex compounds. IV. The chelating tendencies of C-substituted ethylenediamines with copper (II) and nickel (II) ions; J. Am. Chem. Soc., 1954, vol. 76, p. 956-959.
Sunil A. Pansare, Stereoselective synthesis of 3,4-disubstituted 1,2,5-thiadiazolidine 1,1, dioxides and their conversion to unsymmetrical vicinal diamines; Synlett, 1998, vol. 6, p. 623-624.
Hayden T Revert et al, Radiosynthesis of a ligand for studying the glycine transporter, Journal of Labelled Compounds and Radiopharmaceuticals, 2001, vol. 44, p241-246.
Bradley Daniel Marcus
Porter Roderick Alan
Gimmi Edward R.
Glaxo Group Limited
Kanagy James M.
Kinzig Charles M.
Sullivan Daniel M
LandOfFree
Glycine transport inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycine transport inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycine transport inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4159846